Evoltra and capillary leak syndrome Patient Reports February 13, 2012



Evoltra Side Effects Report #5985284-0
Evoltra side effect was reported by a Consumer or non-health professional from FRANCE on Nov 24, 2008. Female patient, child 6 years of age, weighting 35.27 lb, was diagnosed with acute leukaemia and was treated with Evoltra. After drug was administered, patient experienced the following side effects: capillary leak syndrome, febrile bone marrow aplasia, haemodialysis, multi-organ failure, renal failure acute, respiratory failure. Evoltra dosage: unknown. During the same period patient was treated with ENDOXAN, ETOPOSIDE, TAZOCILLINE, AMIKACIN, FASTURTEC, NUBAIN, ZOVIRAX, ZOFRAN. Patient died on 11/09/2008.

Evoltra Side Effects Report #5989642-X
Evoltra side effect was reported by a Physician from GREECE on Nov 27, 2008. Male patient, weighting 165.3 lb, was diagnosed with acute leukaemia and was treated with Evoltra. After drug was administered, patient experienced the following side effects: blood potassium decreased, bradycardia, capillary leak syndrome, haemoptysis, hypotension, lung disorder, pericarditis, sepsis What is  sepsis, systemic inflammatory response syndrome. Evoltra dosage: 20 MG/M2, QD, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, ZOVIRAX, DIANICOTYL. Patient was hospitalized. Patient died on 11/17/2008.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Evoltra